Table 5.
Multilayer Components | Drug | Diagnostic Probe | Purpose | Reference |
---|---|---|---|---|
poly-(l-ornithine) and fucoidan | doxorubicin (pre-loaded combined with fucoidan layers) | fluorescent probe | anticancer | Wang et al. [284] |
PLL and folic acid (or mixture of folic acid and folate antimetabolites) | folic acid (or mixture of folic acid and folate antimetabolites) included as layers | fluorescent probe | anticancer | Rosch et al. [285]. |
poly-l-arginine and dextran sulfate | magnetite particles (pre-loaded within the template or adsorbed as layers) |
magnetite particles (NMR imaging) |
anticancer | Svenskaya et al. [286] |
PLL and poly-l-glutamic acid | doxorubicin (preloaded in the oil core of the emulsion droplets used as template) |
Fe2O3 nanoparticles (NMR imaging) |
anticancer | Szczepanowicz et al. [287] |
dextran, protamine, chitosan, and folic acid | curcumin (post-loaded by direct incubation) |
fluorescent probe (dextran marked with rhodamine as layer) |
anticancer | Hanafy [288] |
PAH and PSS | doxorubicin (pre-loaded in CaCO3 templates) |
quantum dots (fluorescence imaging) |
anticancer | Kalinechenko et al. [36] |
tannic acid and poly(N-vinylpyrrolidone) | doxorubicin (pre-loaded in the template) |
capsule itself ultrasound imaging |
anticancer | Chen et al. [289] |
tannic acid and poly(N-vinylpyrrolidone) | doxorubicin (pre-loaded in silicon dioxide templates) |
iron nanoparticles (NMR imaging) |
anticancer | Alford et al. [290] |
tannic acid and poly(N-vinylpyrrolidone) | doxorubicin (post-loaded by direct incubation) |
89Zr (PET imaging) |
anticancer | Kozlovskaya et al. [291] |
tannic acid and bovine serum albumin |
225Ac (pre-loading by radiolabeling) |
89Zr (PET imaging) |
anticancer | Muslimov et al. [292] |
poly-l-arginine and dextran sulfate | doxorubicin (pre-loaded in CaCO3 templates) |
fluorescent probes and magnetic nanoparticles (fluorescent tomography and optoacoustic signal) |
anticancer | Novoselova et al. [294] |